No Data
No Data
Beam Therapeutics Inc. (BEAM): Is This Gene Therapy Stock a Good Buy Right Now?
Cathie Wood's ARK Investment Buys 116K Shares of Beam Therapeutics Today
Trending Industry Today: Beam Therapeutics Leads Losses In Gene Editing Stocks
Beam Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Editas Cut to Equal Weight by Wells Fargo Over Reni-cel Positioning
Why Beam Therapeutics (BEAM) Is the Worst ARK Stock to Buy According to Short Sellers